Literature DB >> 11455195

A novel mutation in the mitochondrial 16S rRNA gene in a patient with MELAS syndrome, diabetes mellitus, hyperthyroidism and cardiomyopathy.

R H Hsieh1, J Y Li, C Y Pang, Y H Wei.   

Abstract

Using RNase protection analysis, we found a novel C to G mutation at nucleotide position 3093 of mitochondrial DNA (mtDNA) in a previously reported 35-year-old woman exhibiting clinical features of mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) syndrome together with diabetes mellitus, hyperthyroidism and cardiomyopathy. The patient also had an A3243G mutation in the tRNA(Leu(UUR)) gene and a 260-base pair duplication in the D-loop of mtDNA. The fibroblasts of the patient were cultured and used for the construction of cybrids using cytoplasmic transfer of the patient's mtDNA to the mtDNA-less rho(0) cells. RNA isolated from the cybrids was subjected to RNase protection analysis, and a C3093G transversion at the 16S rRNA gene and a MELAS-associated A3243G mutation of mtDNA were detected. The novel C3093G mutation together with the A3243G transition were found in muscle biopsies, hair follicles and blood cells of this patient and also in her skin fibroblasts and cybrids. The proportion of the C3093G mutant mtDNA in muscle biopsies of the patient was 51%. In contrast, the mutation was not detected in three sons of the proband. To characterize the impact of the mtDNA mutation-associated defects on mitochondrial function, we determined the respiratory enzyme activities of the primary culture of fibroblasts established from the proband, her mother and her three sons. The proportions of mtDNA with the C3093G transversion and the A3243G transition in the fibroblasts of the proband were 45 and 58%, respectively. However, the fibroblasts of the proband's mother and children harbored lower levels of mtDNA with the A3243G mutation but did not contain the C3093G mutation. The complex I activity in the proband's fibroblasts was decreased to 47% of the control but those of the fibroblasts of the mother and three sons of the proband were not significantly changed. These findings suggest that the C3093G transversion together with the A3243G transition of mtDNA impaired the respiratory function of mitochondria and caused the atypical MELAS syndrome associated with diabetes mellitus, hyperthyroidism and cardiomyopathy in this patient. Copyright 2001 National Science Council, ROC and S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11455195     DOI: 10.1007/BF02258374

Source DB:  PubMed          Journal:  J Biomed Sci        ISSN: 1021-7770            Impact factor:   8.410


  16 in total

1.  Diagnosis of mitochondrial disorders applying massive pyrosequencing.

Authors:  Marcelo Andrés Kauffman; Dolores Gonzlez-Morón; Damián Consalvo; Gastón Westergaard; Martín Vazquez; Estefanía Mancini; Ana Lía Taratuto; Raúl Rey; Silvia Kochen
Journal:  Mol Biol Rep       Date:  2012-06       Impact factor: 2.316

Review 2.  Multisystem manifestations of mitochondrial disorders.

Authors:  Stefano Di Donato
Journal:  J Neurol       Date:  2009-03-01       Impact factor: 4.849

3.  Bayesian network and mechanistic hierarchical structure modeling of increased likelihood of developing intractable childhood epilepsy from the combined effect of mtDNA variants, oxidative damage, and copy number.

Authors:  Brenda Luna; Sanjiv Bhatia; Changwon Yoo; Quentin Felty; David I Sandberg; Michael Duchowny; Ziad Khatib; Ian Miller; John Ragheb; Jayakar Prasanna; Deodutta Roy
Journal:  J Mol Neurosci       Date:  2014-07-16       Impact factor: 3.444

4.  Mitochondrial DNA Sequence Variation Associated With Peripheral Nerve Function in the Elderly.

Authors:  Shana M Katzman; Elsa S Strotmeyer; Michael A Nalls; Yiqiang Zhao; Sean Mooney; Nik Schork; Anne B Newman; Tamara B Harris; Kristine Yaffe; Steven R Cummings; Yongmei Liu; Gregory J Tranah
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-11-13       Impact factor: 6.053

Review 5.  Mitochondrial translation and beyond: processes implicated in combined oxidative phosphorylation deficiencies.

Authors:  Paulien Smits; Jan Smeitink; Lambert van den Heuvel
Journal:  J Biomed Biotechnol       Date:  2010-04-13

Review 6.  Mouse models of oxidative phosphorylation defects: powerful tools to study the pathobiology of mitochondrial diseases.

Authors:  Alessandra Torraco; Francisca Diaz; Uma D Vempati; Carlos T Moraes
Journal:  Biochim Biophys Acta       Date:  2008-06-13

7.  Pulmonary artery hypertension in a child with MELAS due to a point mutation of the mitochondrial tRNA((Leu)) gene (m.3243A>G).

Authors:  D M Sproule; J Dyme; J Coku; D de Vinck; E Rosenzweig; W K Chung; D C De Vivo
Journal:  J Inherit Metab Dis       Date:  2008-01-07       Impact factor: 4.982

8.  Structure of the large ribosomal subunit from human mitochondria.

Authors:  Alan Brown; Alexey Amunts; Xiao-Chen Bai; Yoichiro Sugimoto; Patricia C Edwards; Garib Murshudov; Sjors H W Scheres; V Ramakrishnan
Journal:  Science       Date:  2014-10-02       Impact factor: 47.728

Review 9.  The Diseased Mitoribosome.

Authors:  Alberto Ferrari; Samuel Del'Olio; Antoni Barrientos
Journal:  FEBS Lett       Date:  2020-12-22       Impact factor: 4.124

10.  Nuclear factors involved in mitochondrial translation cause a subgroup of combined respiratory chain deficiency.

Authors:  John P Kemp; Paul M Smith; Angela Pyle; Vivienne C M Neeve; Helen A L Tuppen; Ulrike Schara; Beril Talim; Haluk Topaloglu; Elke Holinski-Feder; Angela Abicht; Birgit Czermin; Hanns Lochmüller; Robert McFarland; Patrick F Chinnery; Zofia M A Chrzanowska-Lightowlers; Robert N Lightowlers; Robert W Taylor; Rita Horvath
Journal:  Brain       Date:  2010-12-17       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.